Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Chimia|December 18, 2021
Targeting Phosphoinositide 3-Kinase - Five Decades of Chemical Space ExplorationChiara Borsari, Matthias P WymannChemmedchem|June 11, 2021
Chemical and Structural Strategies to Selectively Target mTOR KinaseChiara Borsari, Martina De Pascale, Matthias P WymannPharmaceuticals (Basel, Switzerland)|February 24, 2024
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and BeyondRicardo A M Serafim, Matthias Gehringer, Chiara BorsariDrug Discovery Today|November 29, 2016
Target-based approaches for the discovery of new antimycobacterial drugsChiara Borsari, Stefania Ferrari, Alberto Venturelli, et al.Journal of Medicinal Chemistry|February 6, 2020
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical BiologyChiara Borsari, Darci J Trader, Annalisa Tait, et al.Chemmedchem|December 20, 2022
The Facets of Diversity: The EFMC PerspectiveChiara Borsari, Brieuc Matagne, Kristina Goncharenko, et al.Chemmedchem|July 13, 2016
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase CaseLydia Siragusa, Rosaria Luciani, Chiara Borsari, et al.Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 23, 2019
Excited-state intramolecular proton transfer in a bioactive flavonoid provides fluorescence observables for recognizing its engagement with target proteinsDavide Vanossi, Monica Caselli, Giorgia Pavesi, et al.European Journal of Medicinal Chemistry|August 13, 2016
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitorsAlessia Catalano, Rosaria Luciani, Alessia Carocci, et al.RSC Medicinal Chemistry|May 27, 2021
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeabilityChiara Borsari, Erhan Keles, Andrea Treyer, et al.Pageof 5